Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus propofol for myocardial and renal protection in double valve surgery
2022-003638-38Phase 4Active
- Sponsor
- Fundación IMABIS
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sevoflurane and propofol in Cardiac valve disease (VHD) (2 arms), sponsored by Fundación IMABIS. Primary endpoints: Myocardial damage and injury compared between sevoflurane and propofol, NT-proBNP levels and 3 more. Started Apr 2023; status: active.
02
Drugs
sevofluranepropofol
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on 2022-003638-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003638-38.